A subsidiary of Johnson & Johnson has been ordered to pay $3.35 million in the first transvaginal mesh lawsuit to be settled in court. The court will also consider more than $16 million in punitive damages, which are designed to punish defendants found guilty of unlawful behavior.
The jury ruled that J&J’s Ethicon unit failed to warn Linda Gross or her surgeon of the possible risks associated with its Gynecare Prolift vaginal mesh implant. Gross had to have 18 revision surgeries to correct transvaginal mesh side effects associated with the defective device.
The Gynecare Prolift lawsuit is the first of more than 2,100 filed against the company alleging that product was defective and patients were not warned of the risks. Other mesh manufacturers including C.R. Bard are also facing transvaginal mesh lawsuits. Many manufacturers have issued transvaginal mesh recalls after the Food and Drug Administration requested additional safety information concerning the mesh devices.